Literature DB >> 25888115

C-Linker Accounts for Differential Sensitivity of ERG1 and ERG2 K+ Channels to RPR260243-Induced Slow Deactivation.

Alison Gardner1, Michael C Sanguinetti2.   

Abstract

Compounds can activate human ether-à-go-go-related gene 1 (hERG1) channels by several different mechanisms, including a slowing of deactivation, an increase in single channel open probability, or a reduction in C-type inactivation. The first hERG1 activator to be discovered, RPR260243 ((3R,4R)-4-[3-(6-methoxyquinolin-4-yl)-3-oxo-propyl]-1-[3-(2,3,5-trifluorophenyl)-prop-2-ynyl]-piperidine-3-carboxylic acid) (RPR) induces a pronounced, voltage-dependent slowing of hERG1 deactivation. The putative binding site for RPR, previously mapped to a hydrophobic pocket located between two adjacent subunits, is fully conserved in the closely related rat ether-à-go-go-related gene 2 (rERG2), yet these channels are relatively insensitive to RPR. Here, we use site-directed mutagenesis and heterologous expression of channels in Xenopus oocytes to characterize the structural basis for the differential sensitivity of hERG1 and rERG2 channels to RPR. Analysis of hERG1-rERG2 chimeric channels indicated that the structural determinant of channel sensitivity to RPR was located within the cytoplasmic C-terminus. Analysis of a panel of mutant hERG1 and rERG2 channels further revealed that seven residues, five in the C-linker and two in the adjacent region of the cyclic nucleotide-binding homology domain, can fully account for the differential sensitivity of hERG1 and rERG2 channels to RPR. These findings provide further evidence that the C-linker is a key structural component of slow deactivation in ether-à-go-go-related gene channels.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25888115      PMCID: PMC4468633          DOI: 10.1124/mol.115.098384

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  36 in total

1.  Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death.

Authors:  A JERVELL; F LANGE-NIELSEN
Journal:  Am Heart J       Date:  1957-07       Impact factor: 4.749

2.  Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.

Authors:  Jiesheng Kang; Xiao-Liang Chen; Hongge Wang; Junzhi Ji; Hsien Cheng; Josephine Incardona; William Reynolds; Fabrice Viviani; Michel Tabart; David Rampe
Journal:  Mol Pharmacol       Date:  2004-11-17       Impact factor: 4.436

3.  NMR solution structure of the N-terminal domain of hERG and its interaction with the S4-S5 linker.

Authors:  Qingxin Li; Shovanlal Gayen; Angela Shuyi Chen; Qiwei Huang; Manfred Raida; Congbao Kang
Journal:  Biochem Biophys Res Commun       Date:  2010-11-03       Impact factor: 3.575

4.  Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.

Authors:  Matthew Perry; Frank B Sachse; Michael C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-10       Impact factor: 11.205

5.  Role of intracellular domains in the function of the herg potassium channel.

Authors:  Moza Al-Owais; Kate Bracey; Dennis Wray
Journal:  Eur Biophys J       Date:  2009-01-27       Impact factor: 1.733

6.  The N-terminal tail of hERG contains an amphipathic α-helix that regulates channel deactivation.

Authors:  Chai Ann Ng; Mark J Hunter; Matthew D Perry; Mehdi Mobli; Ying Ke; Philip W Kuchel; Glenn F King; Daniela Stock; Jamie I Vandenberg
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

7.  A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator.

Authors:  Matthew Perry; Michael C Sanguinetti
Journal:  Mol Pharmacol       Date:  2007-12-27       Impact factor: 4.436

8.  Modification of hERG1 channel gating by Cd2+.

Authors:  Jennifer Abbruzzese; Frank B Sachse; Martin Tristani-Firouzi; Michael C Sanguinetti
Journal:  J Gen Physiol       Date:  2010-08       Impact factor: 4.086

9.  hERG potassium channel gating is mediated by N- and C-terminal region interactions.

Authors:  Ahleah S Gustina; Matthew C Trudeau
Journal:  J Gen Physiol       Date:  2011-03       Impact factor: 4.086

10.  Mechanistic insight into human ether-à-go-go-related gene (hERG) K+ channel deactivation gating from the solution structure of the EAG domain.

Authors:  Frederick W Muskett; Samrat Thouta; Steven J Thomson; Alexander Bowen; Phillip J Stansfeld; John S Mitcheson
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

View more
  1 in total

1.  Investigating the utility of adult zebrafish ex vivo whole hearts to pharmacologically screen hERG channel activator compounds.

Authors:  Christina M Hull; Christine E Genge; Yuki Hobbs; Kaveh Rayani; Eric Lin; Marvin Gunawan; Sanam Shafaattalab; Glen F Tibbits; Tom W Claydon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-30       Impact factor: 3.619

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.